Abstract
Peripheral nerve injury is followed by Wallerians degeneration (WD) and degradation and regeneration of the extracellular matrix (ECM) are very important events in these processes. We tested fibrinolytic activities and the expression level of tPA and uPA levels in chronic constriction injury (CCI) model. The presented data demonstrates that in the injury nerve of CCI model, the fibrinolytic activities is upregulated and main caused by the upregulation of tPA expression. We also find that the activities of tPA and MMP-9 are co-upregulated post-CCI, both at CCI site and proximal site. These results indicate that tPA activity may regulate the MMP-9 activity in injury nerve post-CCI.
Similar content being viewed by others
References
Beirowski B, Adalbert R, Wagner D (2005) The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci 6:6. doi:10.1186/1471-2202-6-6
Wagner R, Heckman HM, Myers RR (1998) Wallerian degeneration and hyperalgesia after peripheral nerve injury are glutathione-dependent. Pain 77:173–179. doi:10.1016/S0304-3959(98)00091-8
Platt CI, Krekoski CA, Ward RV et al (2003) Extracellular matrix and matrix metalloproteinases in sciatic nerve. J Neurosci Res 74:417–429. doi:10.1002/jnr.10783
Akassoglou K, Kombrinck KW, Degen JL et al (2000) Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury. J Cell Biol 149:1157–1166. doi:10.1083/jcb.149.5.1157
Siconolfi LB, Seeds NW (2001) Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush. J Neurosci 21:4348–4355
Gantus MA, Nasciutti LE, Cruz CM et al (2006) Modulation of extracellular matrix components by metalloproteinases and their tissue inhibitors during degeneration and regeneration of rat sural nerve. Brain Res 1122:36–46. doi:10.1016/j.brainres.2006.09.016
Krekoski CA, Neubauer D, Graham JB et al (2002) Metalloproteinase-dependent predegeneration in vitro enhances axonal regeneration within acellular peripheral nerve grafts. J Neurosci 22:10408–10415
Bugge TH, Kombrinck KW, Flick MJ et al (1996) Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87:709–719. doi:10.1016/S0092-8674(00)81390-2
Tsirka SE (2002) Tissue plasminogen activator as a modulator of neuronal survival and function. Biochem Soc Trans 30:222–225. doi:10.1042/BST0300222
Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87–107. doi:10.1016/0304-3959(88)90209-6
Gabay E, Tal M (2004) Pain behavior and nerve electrophysiology in the CCI model of neuropathic pain. Pain 110:354–360. doi:10.1016/j.pain.2004.04.021
Selistre-de-Araujo HS, Souza EL, Beltramini LM et al (2000) Expression, refolding, and activity of a recombinant nonhemorrhagic snake venom metalloprotease. Protein Expr Purif 19:41–47. doi:10.1006/prep.2000.1225
Shubayev VI, Myers RR (2000) Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Res 855:83–89. doi:10.1016/S0006-8993(99)02321-5
Leppert D, Waubant E, Galardy R et al (1995) T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 154:4379–4389
Chandler S, Miller KM, Clements JM, Lury J et al (1997) Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol 72:155–161. doi:10.1016/S0165-5728(96)00179-8
Sommer C, Lalonde A, Heckman HM et al (1995) Quantitative neuropathology of a focal nerve injury causing hyperalgesia. J Neuropathol Exp Neurol 54:635–643. doi:10.1097/00005072-199509000-00004
Chattopadhyay S, Myers RR, Janes J et al (2007) Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve. Brain Behav Immun 21:561–568. doi:10.1016/j.bbi.2006.10.015
Shubayev VI, Angert M, Dolkas J et al (2006) TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve. Mol Cell Neurosci 31:407–415. doi:10.1016/j.mcn.2005.10.011
Yong VW, Krekoski CA, Forsyth PA et al (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 21:75–80. doi:10.1016/S0166-2236(97)01169-7
Siconolfi LB, Seeds NW (2003) Mice lacking tissue plasminogen activator and urokinase plasminogen activator genes show attenuated matrix metalloproteases activity after sciatic nerve crush. J Neurosci Res 74:430–434. doi:10.1002/jnr.10786
Sommer C, Schmidt C, George A et al (1997) A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy. Neurosci Lett 237:45–48. doi:10.1016/S0304-3940(97)00813-6
Acknowledgments
We thank Professor Xie Yikuang and Doctor Zhang Xiuling (Peking Union Medical Collage) for their skillful techniques assistance in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yong, N., Guoping, C. The Role and Mechanism of the Up-Regulation of Fibrinolytic Activity in Painful Peripheral Nerve Injury. Neurochem Res 34, 587–592 (2009). https://doi.org/10.1007/s11064-008-9826-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-008-9826-2